Piezo Motion’s New Micro-Dosing Pump Simplifies Laboratory Fluid Handling
Piezo Motion has introduced a new micro-dosing pump that can replace separate lab devices traditionally used for fluid handling applications.
Piezo Motion, a US-based provider of precision motor technology, has introduced a new piezoelectric micro-dosing pump, a first-of-its-kind technology that enables accurate fluid handling applications for scientists across life science laboratories. The company’s innovative design, launched in March 2021, eliminates the drivetrain of traditional pumps by replacing it with a drive mechanism that provides improved performance and responsiveness.
The design consists of a three-in-one microinjector that provides continuous microflow, rapid micro-dosing, microinjection, micro-suction, rapid sampling, and mixing. The footprint is compact at 3.5" by 4.5". In addition, applications that traditionally require two or three separate laboratory devices can now be replaced with this single piezoelectric micro-dosing pump, the company said in a March 17, 2021 press release.
The micro-dosing pump is capable of precise control over dispensed fluid volumes as small as a single nanoliter droplet size with ultra-smooth delivery. The system also includes a programmable user interface and pre-installed operating software. Both the pump and controller come complete and ready-to-use with stainless-steel foot mounts or optional retort stand attachments.
"At the heart of this micro-dosing pump is our ultra-precise rotary piezo motor. This isn't just a pump, it is a microinjector with unmatched responsiveness and control. Not only does our pump have a small footprint it can also replace multiple laboratory devices," said Hassan Kotob, chairman and CEO of Piezo Motion, in the press release.
Source: Piezo Motion
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Your Ultimate Guide for CMC Testing Support for Gene and Cell Therapy
November 21st 2024Explore the complexities of gene and cell therapy development with our comprehensive guide to Chemistry, Manufacturing, and Controls (CMC) testing. Learn how our expertise ensures the safety, potency, and quality of advanced therapies, supporting your journey from product development through regulatory approval.
